These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 2881820)
1. Use of a combined DTP-polio vaccine in a reduced schedule. Swartz TA; Roumiantzeff M; Peyron L; Stopler T; Drucker J; Epstein I; Leitner L; Goldblum N Dev Biol Stand; 1986; 65():159-66. PubMed ID: 2881820 [TBL] [Abstract][Full Text] [Related]
2. Lack of adjuvant effect of the pertussis component on IPV DTP-polio vaccine in children. Cadoz M; Montagnon B; Yvonnet B; Xueref C; Vincent-Falquet JC; Bandet R; Gibelin N Dev Biol Stand; 1986; 65():153-8. PubMed ID: 2881819 [TBL] [Abstract][Full Text] [Related]
3. [The immunological basis of the administration of DTP-polio vaccine]. Cohen H Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905 [TBL] [Abstract][Full Text] [Related]
4. Pertussis immunization of infants using a new combined DTP-polio vaccine. Drucker J; Schatzmayr H; Grenier B; Ajjan N; Peyron L; Roumiantzeff M Dev Biol Stand; 1985; 61():309-13. PubMed ID: 2872119 [TBL] [Abstract][Full Text] [Related]
5. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults. Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of a new combined inactivated DPT-polio vaccine. Drucker J; Soula G; Diallo O; Fabre P Dev Biol Stand; 1986; 65():145-51. PubMed ID: 3030861 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous administration of diphtheria/tetanus/pertussis/polio vaccine and hepatitis B vaccine in a simplified immunization programme. Coursaget P; Yvonnet B; Relyveld EH; Barres JL; Diop-Mar I; Chiron JP Dev Biol Stand; 1986; 65():169-75. PubMed ID: 2881821 [TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses. Halperin SA; King J; Law B; Mills E; Willems P Clin Infect Dis; 1999 May; 28(5):995-1001. PubMed ID: 10452624 [TBL] [Abstract][Full Text] [Related]
10. Vaccination against polio. Inactivated polio vaccine used in The Netherlands and Burkina Faso. Rümke HC Trop Geogr Med; 1993; 45(5):202-5. PubMed ID: 8279056 [No Abstract] [Full Text] [Related]
11. [Antibody response to the fractionated administration of the 2d or 3d basic vaccination injection with a mixed vaccine against diphtheria, tetanus and pertussis]. Vodicková M; Svandová E Cesk Pediatr; 1986 Jun; 41(6):321-3. PubMed ID: 2872973 [No Abstract] [Full Text] [Related]
12. Diphtheria and tetanus toxoids and pertussis vaccine adsorbed (DTP): response to varying immunizing dosage and schedule. Barkin RM; Samuelson JS; Gotlin LP Dev Biol Stand; 1985; 61():297-307. PubMed ID: 2872117 [TBL] [Abstract][Full Text] [Related]
13. Determination of circulating antibodies directed to pertussis toxin and of agglutinogens in children vaccinated with either the whole cell or component pertussis vaccine in France, Japan and Senegal. Relyveld E; Oato NH; Guérin N; Coursaget P; Huet M; Gupta RK Vaccine; 1991 Nov; 9(11):843-50. PubMed ID: 1759508 [TBL] [Abstract][Full Text] [Related]
14. One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine. Lin TY; Wang YH; Huang YC; Chiu CH; Lin PY; Chen CJ; Chavand P; Ortiz E Int J Infect Dis; 2007 Nov; 11(6):488-95. PubMed ID: 17349809 [TBL] [Abstract][Full Text] [Related]
15. The value of booster vaccinations against diphtheria, tetanus, pertussis and poliomyelitis. Gabutti G J Prev Med Hyg; 2008 Mar; 49(1):47-54. PubMed ID: 18792533 [No Abstract] [Full Text] [Related]
16. A modified schedule for routine pertussis immunization. Swartz TA; Roumiantzeff M; Peyron L; Stopler T; Kanaaneh H; Leitner L; Goldblum N Dev Biol Stand; 1985; 61():289-96. PubMed ID: 2872116 [TBL] [Abstract][Full Text] [Related]
17. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age. Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985 [TBL] [Abstract][Full Text] [Related]
18. Age and dose interval as factors in agglutinin formation to pertussis vaccine. Wilkins J; Chan LS; Wehrle PF Vaccine; 1987 Mar; 5(1):49-54. PubMed ID: 2883784 [TBL] [Abstract][Full Text] [Related]
19. [The immunogenicity of vaccines against diphtheria, tetanus, pertussis and polio administered orally on the vaccinal calendar at the age of 2, 4 and 6 months and their coadministration with a hepatitis B vaccine at 0, 2 and 6 months]. Arístegui Fernández J; Muñiz Saitua J; Pérez Legorburu A; Imaz Pérez M; Arrate Zugazabeitia JP; Suárez Fernández MD; Goiri Zabala MD An Esp Pediatr; 1996 Jan; 44(1):25-8. PubMed ID: 8849056 [TBL] [Abstract][Full Text] [Related]
20. A two-dose schedule for immunization of infants using a more concentrated DPT-vaccine. Mangay-Angara A; Fulgencio L; Casabal G; Gudani L; Sumpaico J; Ocampo A; Nagel J; Hagenaars AM; van Hemert PA; Cohen H Dev Biol Stand; 1978; 41():15-22. PubMed ID: 753647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]